BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

240 related articles for article (PubMed ID: 21487019)

  • 1. Fibroblast growth factor receptor 3 (FGFR3) is a strong heat shock protein 90 (Hsp90) client: implications for therapeutic manipulation.
    Laederich MB; Degnin CR; Lunstrum GP; Holden P; Horton WA
    J Biol Chem; 2011 Jun; 286(22):19597-604. PubMed ID: 21487019
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Specific regulation of noncanonical p38alpha activation by Hsp90-Cdc37 chaperone complex in cardiomyocyte.
    Ota A; Zhang J; Ping P; Han J; Wang Y
    Circ Res; 2010 Apr; 106(8):1404-12. PubMed ID: 20299663
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Protein quality control of DYRK family protein kinases by the Hsp90-Cdc37 molecular chaperone.
    Miyata Y; Nishida E
    Biochim Biophys Acta Mol Cell Res; 2021 Sep; 1868(10):119081. PubMed ID: 34147560
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Dynamic tyrosine phosphorylation modulates cycling of the HSP90-P50(CDC37)-AHA1 chaperone machine.
    Xu W; Mollapour M; Prodromou C; Wang S; Scroggins BT; Palchick Z; Beebe K; Siderius M; Lee MJ; Couvillon A; Trepel JB; Miyata Y; Matts R; Neckers L
    Mol Cell; 2012 Aug; 47(3):434-43. PubMed ID: 22727666
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Disease Variants of FGFR3 Reveal Molecular Basis for the Recognition and Additional Roles for Cdc37 in Hsp90 Chaperone System.
    Bunney TD; Inglis AJ; Sanfelice D; Farrell B; Kerr CJ; Thompson GS; Masson GR; Thiyagarajan N; Svergun DI; Williams RL; Breeze AL; Katan M
    Structure; 2018 Mar; 26(3):446-458.e8. PubMed ID: 29478821
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Coordinated regulation of serum- and glucocorticoid-inducible kinase 3 by a C-terminal hydrophobic motif and Hsp90-Cdc37 chaperone complex.
    Wang Y; Xu W; Zhou D; Neckers L; Chen S
    J Biol Chem; 2014 Feb; 289(8):4815-26. PubMed ID: 24379398
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Molecular chaperone complexes with antagonizing activities regulate stability and activity of the tumor suppressor LKB1.
    Gaude H; Aznar N; Delay A; Bres A; Buchet-Poyau K; Caillat C; Vigouroux A; Rogon C; Woods A; Vanacker JM; Höhfeld J; Perret C; Meyer P; Billaud M; Forcet C
    Oncogene; 2012 Mar; 31(12):1582-91. PubMed ID: 21860411
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific association of a set of molecular chaperones including HSP90 and Cdc37 with MOK, a member of the mitogen-activated protein kinase superfamily.
    Miyata Y; Ikawa Y; Shibuya M; Nishida E
    J Biol Chem; 2001 Jun; 276(24):21841-8. PubMed ID: 11278794
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Blocking the chaperone kinome pathway: mechanistic insights into a novel dual inhibition approach for supra-additive suppression of malignant tumors.
    Grover A; Shandilya A; Agrawal V; Pratik P; Bhasme D; Bisaria VS; Sundar D
    Biochem Biophys Res Commun; 2011 Jan; 404(1):498-503. PubMed ID: 21144839
    [TBL] [Abstract][Full Text] [Related]  

  • 10. HSP90-CDC37 functions as a chaperone for the oncogenic FGFR3-TACC3 fusion.
    Li T; Mehraein-Ghomi F; Forbes ME; Namjoshi SV; Ballard EA; Song Q; Chou PC; Wang X; Parker Kerrigan BC; Lang FF; Lesser G; Debinski W; Yang X; Zhang W
    Mol Ther; 2022 Apr; 30(4):1610-1627. PubMed ID: 35151844
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Targeting CDC37: an alternative, kinase-directed strategy for disruption of oncogenic chaperoning.
    Smith JR; Workman P
    Cell Cycle; 2009 Feb; 8(3):362-72. PubMed ID: 19177013
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Regulation of Ubiquitin-like with Plant Homeodomain and RING Finger Domain 1 (UHRF1) Protein Stability by Heat Shock Protein 90 Chaperone Machinery.
    Ding G; Chen P; Zhang H; Huang X; Zang Y; Li J; Li J; Wong J
    J Biol Chem; 2016 Sep; 291(38):20125-35. PubMed ID: 27489107
    [TBL] [Abstract][Full Text] [Related]  

  • 13. p50(cdc37) acting in concert with Hsp90 is required for Raf-1 function.
    Grammatikakis N; Lin JH; Grammatikakis A; Tsichlis PN; Cochran BH
    Mol Cell Biol; 1999 Mar; 19(3):1661-72. PubMed ID: 10022854
    [TBL] [Abstract][Full Text] [Related]  

  • 14. HSP90 is required for TAK1 stability but not for its activation in the pro-inflammatory signaling pathway.
    Liu XY; Seh CC; Cheung PC
    FEBS Lett; 2008 Dec; 582(29):4023-31. PubMed ID: 19026643
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel C-terminal homologue of Aha1 co-chaperone binds to heat shock protein 90 and stimulates its ATPase activity in Entamoeba histolytica.
    Singh M; Shah V; Tatu U
    J Mol Biol; 2014 Apr; 426(8):1786-98. PubMed ID: 24486610
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The Activity and Stability of p56Lck and TCR Signaling Do Not Depend on the Co-Chaperone Cdc37.
    Kowallik S; Kritikos A; Kästle M; Thurm C; Schraven B; Simeoni L
    Int J Mol Sci; 2020 Dec; 22(1):. PubMed ID: 33374422
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Stability of the Peutz-Jeghers syndrome kinase LKB1 requires its binding to the molecular chaperones Hsp90/Cdc37.
    Nony P; Gaude H; Rossel M; Fournier L; Rouault JP; Billaud M
    Oncogene; 2003 Dec; 22(57):9165-75. PubMed ID: 14668798
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Cks1 proteasomal degradation is induced by inhibiting Hsp90-mediated chaperoning in cancer cells.
    Khattar V; Fried J; Xu B; Thottassery JV
    Cancer Chemother Pharmacol; 2015 Feb; 75(2):411-20. PubMed ID: 25544127
    [TBL] [Abstract][Full Text] [Related]  

  • 19. MUC1 oncoprotein functions in activation of fibroblast growth factor receptor signaling.
    Ren J; Raina D; Chen W; Li G; Huang L; Kufe D
    Mol Cancer Res; 2006 Nov; 4(11):873-83. PubMed ID: 17114345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. FGFR3 translocations in bladder cancer: differential sensitivity to HSP90 inhibition based on drug metabolism.
    Acquaviva J; He S; Zhang C; Jimenez JP; Nagai M; Sang J; Sequeira M; Smith DL; Ogawa LS; Inoue T; Tatsuta N; Knowles MA; Bates RC; Proia DA
    Mol Cancer Res; 2014 Jul; 12(7):1042-54. PubMed ID: 24784839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.